Cushing Triad, also known as the Cushing reflex, is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The triad is named after Harvey Cushing, an American neurosurgeon who first described the condition in 1932. This article provides a comprehensive overview of Cushing Triad, including its diagnosis and treatment.
The diagnosis of Cushing Triad is based on the presence of three clinical signs: hypertension, bradycardia, and an irregular respiratory rate. Hypertension is defined as a systolic blood pressure greater than 150 mmHg and/or a diastolic blood pressure greater than 90 mmHg. Bradycardia is defined as a heart rate less than 60 beats per minute. An irregular respiratory rate is defined as an increase in the respiratory rate of more than 10 breaths per minute or a decrease in the respiratory rate of more than 10 breaths per minute. The diagnosis of Cushing Triad is usually made based on the presence of these three clinical signs. However, in some cases, additional tests may be necessary to confirm the diagnosis. These tests may include computed tomography (CT) or magnetic resonance imaging (MRI) scans of the head, a lumbar puncture to measure the intracranial pressure, and/or an electroencephalogram (EEG) to measure brain activity.
Cushing Triad is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. Other causes of Cushing Triad include meningitis, subarachnoid hemorrhage, and intracranial hypertension due to drug toxicity or metabolic disorders.
The treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure. This may include surgery to remove the tumor or hematoma, or to relieve pressure on the brain. Other treatments may include medications to reduce the pressure, such as diuretics, corticosteroids, and osmotic agents. In some cases, treatment may also include the use of a ventriculostomy, which is a procedure in which a small hole is made in the skull to relieve pressure on the brain. Finally, in some cases, treatment may include the use of a shunt, which is a device that is surgically implanted to divert excess cerebrospinal fluid away from the brain.
Cushing Triad is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The diagnosis of Cushing Triad is based on the presence of these three clinical signs, and additional tests may be necessary to confirm the diagnosis. Treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure, and may include surgery, medications, a ventriculostomy, or a shunt.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation